نتایج جستجو برای: shrna

تعداد نتایج: 5672  

2016
Noriko Tarashima Hidenori Ando Takamitsu Kojima Nozomi Kinjo Yosuke Hashimoto Kazuhiro Furukawa Tatsuhiro Ishida Noriaki Minakawa

The development of a versatile technique to induce RNA interference (RNAi) without immune stimulation in vivo is of interest as existing approaches to trigger RNAi, such as small interfering RNA (siRNA) and plasmid DNA (pDNA) expressing short hairpin RNA (shRNA), present drawbacks arising from innate immune stimulation. To overcome them, an intelligent shRNA expression device (iRed) designed to...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2012
Wen-Shuang Wang Xing-Sheng Yang Min Xia Hai-Yang Jiang Jian-Qing Hou

PURPOSE This study aimed to explore the role of the Twist gene in the epithelial-mesenchymal transition of ovarian cancer. METHODS An RNA interference plasmid expressing a small interfering RNA (siRNA)-targeting Twist (Twist siRNA vector) was designed, constructed, and transfected into the human ovarian cancer cell line A2780. Transfection efficiency was assessed under a fluorescence microsco...

Journal: :International journal of oncology 2015
Chengcheng Zhao Meng Zhang Wenlan Liu Chuanfang Wang Qiusheng Zhang Weiping Li

Pituitary adenomas are among the most prevalent forms of intrinsic brain tumors. Although most pituitary adenomas are benign, some of them may become invasive and cause significant mass effect and hormonal dysfunction. We have previously shown that β-catenin is overexpressed in human pituitary adenomas and its level correlates to tumor grades. In the present study, we further investigated the r...

2014
Masashi Idogawa Tomoko Ohashi Jun Sugisaka Yasushi Sasaki Hiromu Suzuki Takashi Tokino

p53 transduction is a potentially effective cancer therapy but does not result in a good therapeutic response in all human cancers due to resistance to apoptosis. To discover factors that overcome resistance to p53-induced apoptosis, we attempted to identify RNAi sequences that enhance p53-induced apoptosis. We screened a genome-wide lentiviral shRNA library in liver cancer Huh-7 and pancreatic...

Journal: :Nanomedicine : nanotechnology, biology, and medicine 2015
Maria de la Fuente Marie-Christine Jones Manuel J Santander-Ortega Anja Mirenska Preethi Marimuthu Ijeoma Uchegbu Andreas Schätzlein

UNLABELLED Gemcitabine is currently the standard therapy for pancreatic cancer. However, growing concerns over gemcitabine resistance mean that new combinatory therapies are required to prevent loss of efficacy with prolonged treatment. Here, we suggest that this could be achieved through co-administration of RNA interference agents targeting the ubiquitin ligase ITCH. Stable anti-ITCH siRNA an...

Journal: :Biochimica et biophysica acta 2014
Krishna M Boini Min Xia Justin M Abais Guangbi Li Ashley L Pitzer Todd W B Gehr Yang Zhang Pin-Lan Li

Inflammasome, an intracellular inflammatory machinery, has been reported to be involved in a variety of chronic degenerative diseases such as atherosclerosis, autoinflammatory diseases and Alzheimer's disease. The present study hypothesized that the formation and activation of inflammasomes associated with apoptosis associated speck-like protein (ASC) are an important initiating mechanism resul...

Journal: :Nucleic acids research 2003
Xu Gang Xia Hongxia Zhou Hongliu Ding El Bashir Affar Yang Shi Zuoshang Xu

Short hairpin RNAs (shRNAs) transcribed by RNA polymerase III (Pol III) promoters can trigger sequence-selective gene silencing in culture and in vivo and, therefore, may be developed to treat diseases caused by dominant, gain-of-function type of gene mutations. These diseases develop in people bearing one mutant and one wild-type gene allele. While the mutant is toxic, the wild-type performs i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید